4th Quarter - Report

CAPITOL SOLUTIONS for AMGEN USA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1956, To amend the Public Health Services Act to provide for the approval of similar biological products H.R. 1038, To provide for the licensing of comparable and interchangable biological products H.R. 5629, To establish a pathway for licensure of biosimilars biological products

LobbyistCovered position, as disclosed
SARAH CURTIS —
DANIEL C TATE —

Bills named: H.R. 1956 (110th), H.R. 1038 (110th), H.R. 5629 (110th)

Medicare/Medicaid MMM

Issues regarding Medicare payments

LobbyistCovered position, as disclosed
SARAH CURTIS —
DANIEL C TATE —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.